300 related articles for article (PubMed ID: 17055065)
21. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
Wilbanks GA; Streilein JW
J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
[TBL] [Abstract][Full Text] [Related]
22. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells.
Wang Y; O'Rourke J; Cone RE
Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893
[TBL] [Abstract][Full Text] [Related]
23. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
Streilein JW; Niederkorn JY
J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
[TBL] [Abstract][Full Text] [Related]
25. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
26. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
D'Orazio TJ; Niederkorn JY
Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
[TBL] [Abstract][Full Text] [Related]
27. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
Farooq SM; Ashour HM
Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
[TBL] [Abstract][Full Text] [Related]
28. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
Skelsey ME; Mellon J; Niederkorn JY
J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
[TBL] [Abstract][Full Text] [Related]
30. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.
Swanson KA; Zheng Y; Heidler KM; Mizobuchi T; Wilkes DS
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):311-8. PubMed ID: 12959949
[TBL] [Abstract][Full Text] [Related]
31. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
[TBL] [Abstract][Full Text] [Related]
32. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
Wilbanks GA; Mammolenti M; Streilein JW
J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
[TBL] [Abstract][Full Text] [Related]
33. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
34. Expression of Tim-3 is transiently increased before development of anterior chamber-associated immune deviation.
Wang Y; Yang P; Li B; Zhou H; Huang X; Wang Y; Chi W; Zhu X; Zhu L; Kijlstra A
Ocul Immunol Inflamm; 2006 Jun; 14(3):151-6. PubMed ID: 16766398
[TBL] [Abstract][Full Text] [Related]
35. Anterior chamber associated immune deviation induced by TNP-splenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor T-cells.
Waldrep JC; Kaplan HJ
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1086-92. PubMed ID: 6192107
[TBL] [Abstract][Full Text] [Related]
36. Role of inflammatory cytokines in induction of anterior chamber-associated immune deviation.
Okamoto S; Streilein JW
Ocul Immunol Inflamm; 1998 Mar; 6(1):1-11. PubMed ID: 9798188
[TBL] [Abstract][Full Text] [Related]
37. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
D'Orazio TJ; Niederkorn JY
J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
[TBL] [Abstract][Full Text] [Related]
38. Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells.
Paunicka K; Chen PW; Niederkorn JY
J Leukoc Biol; 2012 Mar; 91(3):475-83. PubMed ID: 22180630
[TBL] [Abstract][Full Text] [Related]
39. GATA-3 expression in the development of anterior chamber associated immune deviation.
Fu T; Yang PZ; Huang XK; Huang Q; Zhou HY; Li B; Zhong HH; Chen X
Chin Med J (Engl); 2005 Dec; 118(23):2000-4. PubMed ID: 16336837
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]